According to the recent study the clinical trial supply market is projected to reach an estimated $4.0 billion by 2028 from $2.7 billion in 2023, at a CAGR of 7.7% from 2023 to 2028. Growth in this market is primarily driven by increasing R&D expenditure by the pharmaceutical and biotechnology companies, growing prevalence of diseases, and the globalization of clinical trials. A more than...